Suppr超能文献

Off-Label Therapies for COVID-19-Are We All In This Together?

作者信息

Alpern Jonathan D, Gertner Elie

机构信息

HealthPartners Institute, Bloomington, Minnesota, USA.

Section of Infectious Diseases, HealthPartners, St. Paul, Minnesota, USA.

出版信息

Clin Pharmacol Ther. 2020 Aug;108(2):182-184. doi: 10.1002/cpt.1862. Epub 2020 May 5.

Abstract
摘要

相似文献

1
Off-Label Therapies for COVID-19-Are We All In This Together?
Clin Pharmacol Ther. 2020 Aug;108(2):182-184. doi: 10.1002/cpt.1862. Epub 2020 May 5.
2
Drug Evaluation during the Covid-19 Pandemic.
N Engl J Med. 2020 Jun 11;382(24):2282-2284. doi: 10.1056/NEJMp2009457. Epub 2020 Apr 14.
3
Hydroxychloroquine for Coronavirus: The Urgent Need for a Moratorium on Prescriptions.
Am J Med. 2020 Sep;133(9):1007-1008. doi: 10.1016/j.amjmed.2020.05.005. Epub 2020 Jun 2.
5
The coronavirus outbreak could make it quicker and easier to trial drugs.
Nature. 2020 Jun;582(7811):172. doi: 10.1038/d41586-020-01524-0.
6
Association Between US Administration Endorsement of Hydroxychloroquine for COVID-19 and Outpatient Prescribing.
J Gen Intern Med. 2020 Sep;35(9):2826-2828. doi: 10.1007/s11606-020-05938-4. Epub 2020 Jun 15.
7
Does hydroxychloroquine combat COVID-19? A timeline of evidence.
J Am Acad Dermatol. 2020 Jul;83(1):e33-e34. doi: 10.1016/j.jaad.2020.04.031. Epub 2020 Apr 10.
8
ACMT Position Statement: Off-Label Prescribing during COVID-19 Pandemic.
J Med Toxicol. 2020 Jul;16(3):342-345. doi: 10.1007/s13181-020-00784-6. Epub 2020 Jun 4.
9
Hydroxychloroquine and azithromycin as potential treatments for COVID-19; clinical status impacts the outcome.
J Pharmacokinet Pharmacodyn. 2020 Jun;47(3):187-188. doi: 10.1007/s10928-020-09689-x. Epub 2020 May 13.
10
Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine.
Int J Antimicrob Agents. 2020 Apr;55(4):105945. doi: 10.1016/j.ijantimicag.2020.105945. Epub 2020 Mar 17.

引用本文的文献

1
Remdesivir for the treatment of COVID-19.
Cochrane Database Syst Rev. 2023 Jan 25;1(1):CD014962. doi: 10.1002/14651858.CD014962.pub2.
3
Pediatric Off-Label Use of Covid-19 Vaccines: Ethical and Legal Considerations.
Hastings Cent Rep. 2021 Nov;51(6):27-32. doi: 10.1002/hast.1296. Epub 2021 Nov 8.
4
Remdesivir for the treatment of COVID-19.
Cochrane Database Syst Rev. 2021 Aug 5;8(8):CD014962. doi: 10.1002/14651858.CD014962.
5
Inflammatory arthritis in patients with COVID-19.
Transl Res. 2021 Jun;232:49-59. doi: 10.1016/j.trsl.2021.02.010. Epub 2021 Feb 21.
7
Obstacles and Considerations Related to Clinical Trial Research During the COVID-19 Pandemic.
Front Med (Lausanne). 2020 Dec 23;7:598038. doi: 10.3389/fmed.2020.598038. eCollection 2020.
8
Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities.
J Med Chem. 2022 Feb 24;65(4):2716-2746. doi: 10.1021/acs.jmedchem.0c01140. Epub 2020 Nov 13.
9
Meta-analysis on outcome-worsening comorbidities of COVID-19 and related potential drug-drug interactions.
Pharmacol Res. 2020 Nov;161:105250. doi: 10.1016/j.phrs.2020.105250. Epub 2020 Oct 13.
10
Coordinating the research response to COVID-19: Mali's approach.
Health Res Policy Syst. 2020 Sep 17;18(1):105. doi: 10.1186/s12961-020-00623-8.

本文引用的文献

1
Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options.
Open Forum Infect Dis. 2020 Mar 23;7(4):ofaa105. doi: 10.1093/ofid/ofaa105. eCollection 2020 Apr.
2
Race to find COVID-19 treatments accelerates.
Science. 2020 Mar 27;367(6485):1412-1413. doi: 10.1126/science.367.6485.1412.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验